Alambic Investment Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,133
Closed -$155K 5
2020
Q3
$155K Sell
14,133
-13,800
-49% -$109K 1.7% 20
2020
Q2
$184K Sell
27,933
-2,300
-8% -$14.8K 0.46% 101
2020
Q1
$186K Buy
30,233
+2,673
+10% +$21.7K 0.45% 91
2019
Q4
$214K Buy
27,560
+14,757
+115% +$102K 0.18% 204
2019
Q3
$76K Buy
+12,803
New +$81.4K 0.06% 275
2016
Q3
Sell
-14,906
Closed -$74K 511
2016
Q2
$74K Buy
+14,906
New +$65.3K 0.02% 512

Other funds holding ASPN

Alambic Investment Management's ASPN Position: Q4 2020 in Review

Alambic Investment Management sold out of Aspen Aerogels (ASPN) in Q4 2020, closing a stake of 14,133 shares — an estimated $155K sold.

Alambic Investment Management first reported a position in ASPN in Q2 2016 and held it in 6 quarters. The position peaked at $214K in Q4 2019. 76 funds tracked by Wall St. Rank hold ASPN as of Q4 2020.

  • Alambic Investment Management reported no remaining Aspen Aerogels position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 14,133 Aspen Aerogels shares in Q4 2020, an estimated $155K.
  • Alambic Investment Management first reported a position in Aspen Aerogels in Q2 2016 and held it in 6 quarters.
  • Alambic Investment Management's Aspen Aerogels position peaked at $214K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.